As for gender differences in overall PE-fit, homogeneity of variance was given, and while the difference between men ( M = 87.06%) and women ( M = 82.53) was only close to being significant, t (86) = 1.98, p = 0.050, a small to moderate effect size of gender, Cohen’s d = 0.437, was found.
Excerpts
Statistical significance was defined as follows: p ≤ 0.05 was considered significant, p < 0.01 was regarded as highly significant, and p > 0.05 indicated no significant difference. 3.
rostratum showed an increasing trend, the difference was not statistically significant ( p ≥ 0.05).
Analysis of molecular variance (AMOVA) was implemented to evaluate variance components among groups and individuals ( Table 7 ), which showed highly significant differences ( P < 0.05).
The association remained nominally significant in the T2D-unadjusted and case subject-only analyses ( P < 0.05 for both).
According to the Pearson correlation analysis a positive, moderately significant relationship between the EDE-Q total scores and anxiety scores was observed (r=.630, p<.05).
On the other hand, feeling stress due to short-term work problems in the case of women is marginally significant ( p -value = 0.05) related to an increase in telomere length.
In the present study, CRP levels were higher in deceased patients compared to survivors, although this difference was borderline significant ( p = 0.05).
The average P app value of the ZO‐2 KD cell monolayers for the 40 kDa fluorescein‐dextran was smaller than the average P app value for the MDCK II cell monolayers but did not reach statistical significance at the p < 0.05 level.
ROH hotspots contain genes with diverse functions Regarding the gene content of genomic segments co-localising with both high homozygosity regions and ROH hotspots (CHI4:42,552,375–48,378,207 bp), the functional enrichment analysis highlighted several gene ontology terms with nominally significant enrichment ( P -value < 0.05) (Additional file 7 : Table S5).
In case an association did not reach statistical significance at conventional thresholds that account for correction for multiple comparisons (e.g., p < 0.05, familywise error corrected), we explicitly considered the former as providing “exploratory evidence.” ANOVA was used for continuous and normally distributed data and Kruskal–Wallis or Mann–Whitney were used for non-normally distributed data.
For the N290 component, an exploratory 2 (condition: helping, hindering) × 2 (hemisphere: left, right) × 2 (age group: 6-month, 12-month) mixed ANOVA found a significant main effect of age group, F (1, 71)= 7.17, p = .009, η 2 = .09, and a marginally significant main effect of condition, F (1, 71)= 3.99, p = .050, η 2 = .05 (see Fig. 5 ).
The index measured was taken as the statistical unit, and the results were expressed as “mean ± standard error”, where p < 0.01 meant that the difference was extremely significant, and p < 0.05 meant that the difference was significant. 0.05 ≤ p < 0.1 indicates a trend. 3.
Over the same period, increased odds of always having a new syringe for injection was marginally significant (aOR 1.1; p = 0.05, 95% CI 1.0–1.2) (data not shown).
6 h), a downregulation of Cldn5 in Stress WT and a clear trend to decrease in both Sphk2−/− groups (p = 0.05) compared to Control WT (Fig. 6 i), and a lowered Cldn7 expression for Stress Sphk2−/− in comparison to Stress WT (Fig. 6 j).
Both for behavioral and ERP data, main and interaction effects that reached statistical or marginal significance levels ( p < 0.05 or p < 0.08, respectively) in comparison of interest are reported.
We did not observe a significant trend with elevation (ANOVA P >0.05), but this could emerge with additional sampling.
Although it did not reach statistical significance, a trend towards an increase in the development of lower respiratory tract infection was detected in the COVID-19 group compared with the control group (P = 0.05).
At the same time, the nutrient apparent metabolic rate and cecal microbial abundance of each treatment group had an increasing trend (p>0.05).
approached significancep = .05
However, there was a significant positive correlation between problematic use and a self‐reported measure of anxiety symptoms ( p < .05), while the positive correlation between problematic use and self‐reported depression symptoms approached significance ( p = .05) (Gansner et al., 2020 ).
a trend toward significancep = 0.05
This showed a trend toward significance for patients at risk with a timed “up and go” of 11 s (difference in proportions = 0.17, 95% CI: −0.09–0.43; p = 0.05).
Although association of exposure score was not statistically significant, it showed a positive trend (β = 0.02; 95% CI 0.04, 0.00; p-value = 0.05).
SNPs that were identified as being shared loci (GWAS-significant loci for BMI or WHRadjBMI and nominally significant (p < 0.05) for basal or stimulated lipolysis) were used as the exposure.
Competence development only showed a marginally significant association with work‐related exhaustion ( p = .05) when included in the model with efficiency and violence; all other associations were non‐significant.
The correlations between other pairs did not reach statistical significance (α = 0.008; qT1-ICVF, R = −0.49, P = 0.05; qT1-ODI, R = 0.51, P = 0.04; qT1-IsoV, R = −0.60; P = 0.01; ICVF-ODI, R = −0.12, P = 0.65; ODI-IsoV, R = −0.57, P = 0.02), suggesting that these metrics may reflect multiple underlying sources of tissue abnormalities in the OT (see Supplementary Table S1 for the correlations among MRI metrics in healthy controls).